Immunohistochemistry was performed as previously described (17). Antigen retrieval was The Netherlands). Anti-VEGF antibody specificity was assessed as described before (19).
193
Stained surface was quantified with a brightfield immunohistochemistry image analysis 194 program (Leica Biosystems, Wetzlar, Germany).
195
For staining quantification, sections were digitalized at a 20x magnification using an SCN400 196 slide scanner (Leica, Wetzlar, Germany). The tissue in each section was delineated manually 197 and care was taken to exclude tissue folds, bubbles and artefacts from the analysis. Scanned 198 slides were then quantified using Tissue IA (Leica Biosystems, Dublin, Ireland).Color 9 software. On the DAB matrice, a threshold was adjusted for DAB detection according to 201 intensity (grey values from 0 to 255) on representative stained versus not stained tissue areas.
202
In a similar way, a threshold was also adjusted for tissue detection. These parameters were Table 3 . Amplification levels were normalized to those of β-actin. All samples were 215 measured in duplicate. 
ROS measurements

218
ROS production was measured using fluorescent dye Carboxy-DCFDA (5-(and-6)-Carboxy-219 2',7'-Dichlorofluorescein Diacetate) (DCFDA, Invitrogen). Cells were plated in multichamber 220 glass slides (Sigma) in medium containing 10 -8 M of NaI until they reached 80% confluence.
221
After washing with PBS, medium was replaced by fresh medium containing NaI or not. After to control, ID increased blood flow from day 1 to day 10 of the treatment (Fig. 1a) . This response, a group of mice received LID food without perchlorate for 4 days, which also 261 induced a significant increase in blood flow (Fig. 1b) .
262
VEGF has been involved in the response of the thyroid vasculature to ID (19). In the 263 mammary gland, RT-qPCR analyses detected a significant increase in VEGF mRNA 264 expression at day 1 of ID ( Fig. 1c) . It went along with increased VEGF protein expression 265 detected by immunohistochemistry around some blood vessels and in the stroma (Fig. 1d-g ).
266
This staining was strongly enhanced from day one ( Fig. 1e-f ) to day 10 of the treatment.
267
Increased staining was also observed in the lumen of the glands and at the apical membrane of 268 the mammary epithelial cells (Fig. 1g) . To assess the involvement of VEGF in the ID-induced 269 increase in blood perfusion, lactating mice were injected with a VEGFR2/1 inhibitor,
270
SU5416, or with the vehicle solution, DMSO. SU5416 prevented the ID-induced increase in 271 blood perfusion, confirming VEGF role this response (Fig. 1h) . Although iodide uptake is very low in non-lactating mammary glands compared to lactating 278 glands (6), acute ID also induced an increase in blood flow in the mammary glands of 8-week 279 old virgin mice (Fig. 2a) . Increased perfusion was detected only at day 1 of treatment. Blood 280 flow then progressively declined to basal level from day 2 to day 10 (Fig. 2a) . A second 281 experiment with longer treatment times revealed no increase in blood flow after ID exposure 282 up to 20 days (Fig. 2b) . Mice that received LID food without perchlorate for 2 days also 283 experienced increased mammary gland blood flow (Fig. 2c) . To verify that the difference in
284
age between lactating and virgin mice was not responsible for the difference in the response
285
induced by ID, 12-week old virgin mice were exposed to ID for 1, 2, 4 or 10 days and their 286 blood perfusion was measured. A similar response was observed (data not shown).
287
To investigate the effects of acute ID on vascularization, blood vessels were labelled
288
with an anti-CD31 antibody. An increase in total stained surface was observed at day 2,
289
showing that the total vascular surface was increased upon ID (Fig. 2d) . However, ID did not
290
induce an increase in the number of vessel sections per unit of surface (Fig. 2e) (Fig. 2f-g ). Comparatively, VEGF 295 expression was enhanced on days 1 and 2 of ID at all 3 locations (Fig. 2h-i) . After 4 days of 296 ID, VEGF expression decreased but was still higher than in controls. At day 10, VEGF 297 expression was similar to the expression in controls.
298
To determine whether VEGF is responsible for ID-induced increase in blood flow,
299
mice were injected either with VEGFR2/1 inhibitor SU5416 or with DMSO as a control.
SU5416 inhibited the increased blood flow in response to acute ID, whereas basal blood flow 301 in iodine-replenished mice was not affected (Fig. 2j) . Similar data were obtained when using
302
VEGF-blocking antibody bevacizumab at a high dose instead of SU5416 (Fig. 2k) found that iodine-deprived cells had increased ROS levels 4 h after ID (Fig. 4b-e) . Oxidative damage was then assessed through 4-HNE adducts measurement by immunofluorescence. An 326 increase in 4-HNE staining was observed at 4 h of ID ( Fig. 4f-g showing that antioxidant NAC prevented the increase in VEGF mRNA levels in cells exposed 329 to ID (Fig. 4h) . NAC had no effect on basal VEGF mRNA expression in control cells.
330
Further, VEGF is a HIF-1-target gene (15), and transcription factor HIF-1 is activated by ROS 331 that increase the expression of its α subunit (23). In line with an involvement of HIF-1 in the 332 response to ID, we observed a significant increase in HIF-1α expression 4 h after ID (Fig. 4i) .
333
NAC prevented ID-induced HIF-1α protein overexpression ( Fig. 4j) , which revealed that 
336
The activity of the transcription factor HIF-1 was then inhibited by echinomycin. As a 337 consequence, the ID-induced effect on VEGF mRNA overexpression was not observed (Fig.   338 4k).
339
In thyrocytes, mTOR promotes HIF-1 and VEGF expression during ID (7), and 340 mTOR activity can be increased by ROS (5). We therefore reasoned that mTOR could be Because our in vitro data unraveled mTOR contribution to ID-induced VEGF mRNA 374 expression, virgin mice were exposed to rapamycin in order to verify that mTOR is also which are known to have a very low iodide intake (6), also reacted to ID by increasing Student's t test (B). * P < 0.05, ** P < 0.01, *** P < 0.001 versus control (A-C, H). Goat anti-mouse poly-HRP 1:5,000 (ThermosFisher Scientific #32230)
30" to 1' (7; 8)
HIF1human
Monoclonal Goat anti-rabbit poly-HRP 1:5,000 (ThermosFisher Scientific #31460) 2 to 4' 
